Trupanion, Inc. $TRUP is Kopion Asset Management LLC’s 3rd Largest Position

Kopion Asset Management LLC lifted its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 20.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 264,603 shares of the financial services provider’s stock after buying an additional 45,594 shares during the period. Trupanion makes up 7.4% of Kopion Asset Management LLC’s portfolio, making the stock its 3rd biggest position. Kopion Asset Management LLC owned about 0.62% of Trupanion worth $11,452,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of TRUP. AlphaQuest LLC lifted its stake in Trupanion by 940.6% during the 1st quarter. AlphaQuest LLC now owns 1,051 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 950 shares during the period. Nisa Investment Advisors LLC raised its holdings in shares of Trupanion by 44.1% during the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 300 shares during the last quarter. GAMMA Investing LLC lifted its position in Trupanion by 30.1% during the second quarter. GAMMA Investing LLC now owns 2,133 shares of the financial services provider’s stock valued at $118,000 after purchasing an additional 494 shares during the period. Contravisory Investment Management Inc. purchased a new stake in Trupanion in the third quarter worth approximately $199,000. Finally, Lake Hills Wealth Management LLC purchased a new stake in Trupanion in the second quarter worth approximately $204,000.

Insider Activity

In other Trupanion news, COO John R. Gallagher sold 6,383 shares of the company’s stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $34.82, for a total value of $222,256.06. Following the completion of the transaction, the chief operating officer directly owned 32,721 shares in the company, valued at $1,139,345.22. This represents a 16.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Margaret Tooth sold 9,803 shares of the stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $35.31, for a total transaction of $346,143.93. Following the completion of the sale, the chief executive officer directly owned 151,899 shares of the company’s stock, valued at approximately $5,363,553.69. This trade represents a 6.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 49,838 shares of company stock valued at $1,915,882 in the last ninety days. Corporate insiders own 5.42% of the company’s stock.

Trupanion Trading Up 0.1%

NASDAQ:TRUP opened at $38.05 on Tuesday. Trupanion, Inc. has a one year low of $31.00 and a one year high of $57.88. The business has a fifty day moving average price of $38.81 and a 200-day moving average price of $44.89. The firm has a market capitalization of $1.64 billion, a price-to-earnings ratio of 105.70 and a beta of 1.62. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.71 and a quick ratio of 1.71.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.76). The company had revenue of $366.92 million for the quarter, compared to the consensus estimate of $361.58 million. Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The business’s revenue for the quarter was up 12.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.03 EPS. Sell-side analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on TRUP. Stifel Nicolaus decreased their target price on shares of Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, December 15th. Piper Sandler reduced their price objective on Trupanion from $67.00 to $60.00 and set an “overweight” rating for the company in a research report on Friday. Finally, Wall Street Zen cut Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Trupanion has a consensus rating of “Hold” and an average price target of $52.25.

Trupanion Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.